We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What is the Anticipated CAGR of the Breast Cancer Screening Test Market, and What Factors Will Drive It?

The market size for breast cancer screening tests has seen significant growth in recent years. Its growth is projected to rise from $2.31 billion in 2024 to $2.51 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The growth experienced during the historical period can be credited to factors such as enhanced reimbursement policies, an increased emphasis on preventive healthcare, higher levels of health consciousness, amplified research and development efforts, and heightened awareness regarding early detection.

The market for breast cancer screening tests is anticipated to experience substantial growth in the coming years, expanding to $3.46 billion in 2029 with a compound annual growth rate (CAGR) of 8.3%. This growth over the predicted period can be linked to a surge in breast cancer cases, expanded governmental activities, increased healthcare spending, the growth of mobile screening units, and the thriving female population. Prominent trends during the predicted period include advancements in imaging technology, the emergence of non-invasive testing techniques, progress in genetic and genomic testing, as well as the expansion of mobile screening solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp

What are the Fundamental Drivers and Innovations Shaping the Breast Cancer Screening Test Market?

The increasing occurrence of breast cancer is anticipated to drive the expansion of the breast cancer screening test market. Uncontrolled growth of abnormal cells in the breast tissue that can form a tumor and potentially metastasize to other body parts is what constitutes breast cancer. The escalating rate of this disease is attributable to the aging global population and increased life expectancies, as age is a significant risk factor for the ailment. Early disease detection is made possible by breast cancer screening tests, thereby enhancing the probability of effective treatment and reducing mortality associated with breast cancer. For instance, in March 2025, Breastcancer.org, a nonprofit organization based in the US, estimates that approximately 316,950 women will be diagnosed with invasive breast cancer, and around 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS) will be reported. Additionally, in December 2024, the Public Health Agency of Canada, a government agency based in Canada, estimates that about 28,600 Canadian women will be diagnosed with breast cancer in 2022, and approximately 5,500 may succumb to the disease. Hence, the escalating incidences of breast cancer are catalyzing the expansion of the breast cancer screening test market.

How Is the Breast Cancer Screening Test Market Segmented?

The breast cancer screening test market covered in this report is segmented –

1) By Diagnostic Test Type: Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test

2) By Risk Level: High-risk Population, Moderate-risk Population, Average-risk Population

3) By End User: Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories

Subsegments

1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test

2) By Imaging Test: Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Tomograph Scan, Ultrasound

3) By Genetic Test: Fluorescence In Situ Hybridization, Her Gene Test

4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp

Which Regions Are Driving the Next Phase of the Breast Cancer Screening Test Market Growth?

North America was the largest region in the breast cancer screening test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Breast Cancer Screening Test Market?

Leading businesses within the breast cancer screening test market are aiming to create pioneering products like transportable cancer screening units, in an effort to improve accessibility, increase early discovery rates, and broaden screening services in remote and underserved locations. A transportable cancer screening unit is a mobile facility equipped with diagnostic imaging technologies, such as mammography, for providing breast cancer screening services on-site in inaccessible or undeserved areas. Granules India Ltd., a pharmaceutical firm from India, serves as an example when they launched the Breast Health Express in September 2024 to enhance breast cancer screening in poverty-stricken communities. This unit incorporates top-notch mammography and ultrasound technology to perform high-standard screenings on the move. The project aims to reach rural and underserved populations potentially facing healthcare access limitations and guarantees that women in distant places can avail of critical early detection procedures.

View the full report here:

https://www.thebusinessresearchcompany.com/report/breast-cancer-screening-test-global-market-report

How Is the Breast Cancer Screening Test Market Defined and What Are Its Core Parameters?

A breast cancer screening test is a medical procedure or diagnostic tool used to detect breast cancer at an early stage, often before symptoms appear. The primary goal of screening is to identify cancer when it is most treatable, potentially reducing mortality and improving outcomes. The breast cancer screening test helps in early diagnosis, allowing for timely intervention and a better prognosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24180&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model